迷走神経刺激装置(VNS):医療機器パイプライン分析2020

GlobalDataが発行した調査報告書(GD21MC040)
◆英語タイトル:Vagus Nerve Stimulators (VNS) - Medical Devices Pipeline Assessment, 2020
◆商品コード:GD21MC040
◆発行会社(リサーチ会社):GlobalData
◆発行日:2020年12月1日
◆ページ数:96
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Vagus Nerve Stimulators (VNS) – Medical Devices Pipeline Assessment, 2020
Summary

GlobalData’s Medical Devices sector report, “Vagus Nerve Stimulators (VNS) – Medical Devices Pipeline Assessment, 2020″ provides comprehensive information about the Vagus Nerve Stimulators (VNS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A VNS is a device comprised of an electrical pacemaker that sends electrical stimulation through surgically-implanted electrodes to target the vagus nerve. VNSs are utilized to treat neurological disorders like epilepsy and depression.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Vagus Nerve Stimulators (VNS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Vagus Nerve Stimulators (VNS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Vagus Nerve Stimulators (VNS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Vagus Nerve Stimulators (VNS) Overview
3 Products under Development
3.1 Vagus Nerve Stimulators (VNS) – Pipeline Products by Stage of Development
3.2 Vagus Nerve Stimulators (VNS) – Pipeline Products by Territory
3.3 Vagus Nerve Stimulators (VNS) – Pipeline Products by Regulatory Path
3.4 Vagus Nerve Stimulators (VNS) – Pipeline Products by Estimated Approval Date
3.5 Vagus Nerve Stimulators (VNS) – Ongoing Clinical Trials
4 Vagus Nerve Stimulators (VNS) – Pipeline Products under Development by Companies
4.1 Vagus Nerve Stimulators (VNS) Companies – Pipeline Products by Stage of Development
4.2 Vagus Nerve Stimulators (VNS) – Pipeline Products by Stage of Development
5 Vagus Nerve Stimulators (VNS) Companies and Product Overview
5.1 Aucta Technologies Inc Company Overview
5.1.1 Aucta Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Boston Scientific Corp Company Overview
5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.3 Cala Health Inc Company Overview
5.3.1 Cala Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 CerboMed GmbH Company Overview
5.4.1 CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cyberonics Inc Company Overview
5.5.1 Cyberonics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 DuoCure Ltd. Company Overview
5.6.1 DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.7 ElectroCore Inc Company Overview
5.7.1 ElectroCore Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 LivaNova PLC Company Overview
5.8.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Medical University of South Carolina Company Overview
5.9.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
5.10 MicroTransponder Inc Company Overview
5.10.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Nemechek Technologies LLC Company Overview
5.11.1 Nemechek Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.12 Nexeon MedSystems Inc Company Overview
5.12.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Otto Bock HealthCare GmbH Company Overview
5.13.1 Otto Bock HealthCare GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.14 Parasym Ltd Company Overview
5.14.1 Parasym Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.15 Pulsus Medical LLC (Inactive) Company Overview
5.15.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.16 Purdue University Company Overview
5.16.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
5.17 Setpoint Medical Corp Company Overview
5.17.1 Setpoint Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.18 Synergia Medical Company Overview
5.18.1 Synergia Medical Pipeline Products & Ongoing Clinical Trials Overview
5.19 SzeleSTIM GmbH Company Overview
5.19.1 SzeleSTIM GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.20 The Feinstein Institute for Medical Research Company Overview
5.20.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
5.21 Trifectas Medical Corp. Company Overview
5.21.1 Trifectas Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview
5.22 University of Pittsburgh Company Overview
5.22.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
5.23 University of Wisconsin Madison Company Overview
5.23.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
6 Vagus Nerve Stimulators (VNS)- Recent Developments
6.1 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
6.2 Mar 09, 2020: LivaNova VNS Therapy System, Symmetry, granted CE Mark for difficult-to-treat depression
6.3 Feb 26, 2020: LivaNova reports fourth quarter and full-year 2019 results
6.4 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019
6.5 Jan 27, 2020: ElectroCore announces rebate agreement with Ascent Health Services for gammaCore preferred brand coverage on all express scripts standard national formularies
6.6 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019
6.7 Jan 13, 2020: electroCore provides business update and select financial guidance
6.8 Dec 27, 2019: electroCore announces board of directors transition
6.9 Dec 20, 2019: LivaNova recalls VNS Therapy SenTiva Generator due to reset error
6.10 Dec 05, 2019: LivaNova to present new data on Vagus Nerve Stimulation Therapy System at the American Epilepsy Society 2019 Annual Meeting
6.11 Dec 03, 2019: NICE recommends the use of gammaCore for the treatment of Cluster Headache in the NHS
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
Table 2: Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
Table 3: Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
Table 4: Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
Table 5: Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials
Table 6: Vagus Nerve Stimulators (VNS) Companies - Pipeline Products by Stage of Development
Table 7: Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
Table 8: Aucta Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: DECIMA Device - Product Status
Table 10: DECIMA Device - Product Description
Table 11: Aucta Technologies Inc - Ongoing Clinical Trials Overview
Table 12: DECIMA Device - This is a Single-site, Double-blind, Randomized, Prospective, Sham-controlled, Crossover Early Feasibility Study to Determine Whether Ultrasound Vagus Nerve Stimulation (uVNS) Inhibits Postprandial Hyperglycemia in Humans
Table 13: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 14: AMT System - Product Status
Table 15: AMT System - Product Description
Table 16: Vagus Nerve Stimulation (VNS) System - Product Status
Table 17: Vagus Nerve Stimulation (VNS) System - Product Description
Table 18: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 19: Vagus Nerve Stimulation (VNS) System - Neural Cardiac Therapy for Heart Failure Study
Table 20: Cala Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Wearable Neuromodulation Device - Product Status
Table 22: Wearable Neuromodulation Device - Product Description
Table 23: CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 24: t-VNS - Dementia - Product Status
Table 25: t-VNS - Dementia - Product Description
Table 26: Cyberonics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Nerve Wrap - Product Status
Table 28: Nerve Wrap - Product Description
Table 29: DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Intraluminal Implantable Device - Product Status
Table 31: Intraluminal Implantable Device - Product Description
Table 32: ElectroCore Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: GammaCore - Gastroenterology - Product Status
Table 34: GammaCore - Gastroenterology - Product Description
Table 35: GammaCore - Neurology - Product Status
Table 36: GammaCore - Neurology - Product Description
Table 37: GammaCore - Post-Traumatic Headache - Product Status
Table 38: GammaCore - Post-Traumatic Headache - Product Description
Table 39: GammaCore - Rheumatoid Arthritis - Product Status
Table 40: GammaCore - Rheumatoid Arthritis - Product Description
Table 41: GammaCore - Sjogren’s Syndrome - Product Status
Table 42: GammaCore - Sjogren’s Syndrome - Product Description
Table 43: GammaCore Sapphire CV - Product Status
Table 44: GammaCore Sapphire CV - Product Description
Table 45: Resolve Stimulator and Proximity Electrode - Product Status
Table 46: Resolve Stimulator and Proximity Electrode - Product Description
Table 47: ElectroCore Inc - Ongoing Clinical Trials Overview
Table 48: GammaCore Sapphire CV - A Prospective, Randomized, Controlled Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIOR)
Table 49: GammaCore Sapphire CV - A Prospective, Randomized, Controlled Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIORII)
Table 50: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
Figure 2: Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
Figure 3: Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
Figure 4: Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
Figure 5: Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 迷走神経刺激装置(VNS):医療機器パイプライン分析2020(Vagus Nerve Stimulators (VNS) - Medical Devices Pipeline Assessment, 2020)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆